UPDATE: Phibro Animal Health (PAHC) Tops Q4 EPS by 2c; Guides FY17 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
August 29, 2016 4:40 PM EDTTEANECK, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2016. It also provided guidance for its fiscal year ending June 30, 2017.
Highlights for the June 2016 quarter (compared to the June 2015 quarter) Net sales of $189 million, an increase of 2%Net income of $15 million, an increase of 46%Diluted EPS of $0.38, an increase of 46%Adjusted EBITDA of $28 million, an increase of 4%Adjusted diluted EPS of $0.40, a decrease of... More